Paolo Tarantino: The Terri Brodeur Foundation Annual Meeting

Paolo Tarantino shared a post on LinkedIn:

”Just back from the Terri Brodeur Foundation Annual Meeting.

So impressed by the kindness, passion and commitment of this organization to raise funds for breast cancer research. So grateful to be among the recipients of their support.

Make sure to follow their activities!”

Source: Paolo Tarantino/LinkedIn

Dr. Paolo Tarantino, MD researcher, holds positions at both the European Institute of Oncology in Milan, Italy, and the Dana-Farber Cancer Institute in Boston, MA, Specializing in breast cancer. Currently, Dr. Tarantino is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan.

His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer. With a robust publication record exceeding 50 papers on breast cancer, he is recognized as a leading expert in the field. Dr. Tarantino’s dedication and innovative approach contribute significantly to the advancement of breast cancer treatment and research.